Holen Sie sich die Stockscreener-App
144.74
1.87%
-2.76
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GILD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten
Confluence Investment Management LLC Cuts Position in Gilead Sciences, Inc. $GILD - MarketBeat
More Upside Awaits for Gilead Sciences Stock. Stay Invested. - Barron's
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Gilead expands lenacapavir licenses: Gilead Sciences stock has 6.53 percent upside - AD HOC NEWS
Gilead Sciences stock pre-market at EUR 131.75: plus 0.54 percent - AD HOC NEWS
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors - Yahoo Finance
Gilead Sciences, Inc. (GILD) stock price, news, quote and history - uk.finance.yahoo.com
Gilead Sciences (NASDAQ:GILD) Stock: Stronger HIV Sales Meet Weaker Reported Earnings - kalkine.ca
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase? - Yahoo Finance
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? - Yahoo Finance
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - Yahoo Finance
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? - Yahoo Finance
Gilead Sciences (GILD) Share Price, News, Stock Market Cap NASDAQ - TechGraph
CEUX:GISd Dividend: Does Gilead Sciences Inc Pay a Dividend? - GuruFocus
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income? - Insider Monkey
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification? - Yahoo Finance
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own? - Insider Monkey
Form 4 Gilead Sciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Has Average Price Target of $158.78 According to Analysts - MarketBeat
Gilead Sciences stock closes at USD 149.69, down 1.11 percent at the close - AD HOC NEWS
UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175 - Moomoo
Gilead Sciences stock falls 1.11 percent despite revenue growth - AD HOC NEWS
Gilead Sciences, Inc. $GILD Stake Decreased by Envestnet Asset Management Inc. - MarketBeat
Gilead Sciences stock heads into the open after a 0.4 percent gain - AD HOC NEWS
Gilead Sciences Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Form DEF 14A Gilead Sciences Inc For: 24 September By Investing.com - Investing.com Canada
Gilead Sciences stock slips 0.85 percent ahead of the open - AD HOC NEWS
Gilead: HIV Growth Is Not Enough At The Current Price (NASDAQ:GILD) - Seeking Alpha
Gilead Sciences stock slips 1.30 percent at the close - AD HOC NEWS
Gilead Sciences, Inc. (GILD) latest stock news and headlines - Yahoo Finance Singapore
Gilead Sciences stock slips as earnings estimates shift - AD HOC NEWS
Can Gilead Sciences (NASDAQ:GILD) turn HIV leadership and oncology development into a stronger market story? - Kalkine Media
Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Gilead Sciences stock slips 0.7 percent ahead of the open - AD HOC NEWS
Gilead Sciences Research Scholars Program in Solid Tumors – US 2026 - Oncodaily
Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH - The Motley Fool
Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know - Yahoo Finance
Gilead Sciences stock slips 0.7 percent at the close - AD HOC NEWS
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Andra AP fonden Sells 11,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences FY2026 EPS Increased by Erste Group Bank - MarketBeat
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Database
Here's How Much $1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth Today - Benzinga
Gilead Sciences stock holds near 52-week high as HIV prevention deal and analyst optimism support va - AD HOC NEWS
Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Revenue Growth and Strategic Collaborations - DirectorsTalk Interviews
Erste Group Bank Estimates Gilead Sciences FY2027 Earnings - MarketBeat
Gilead Sciences stock heads into the open after a 0.52% dip - ad-hoc-news.de
Gilead Sciences stock gains as HIV drug access expands - AD HOC NEWS
Why Morgan Stanley likes Gilead’s HIV prevention play - thestreet.com
Why Is Gilead Sciences (GILD) Widening Lenacapavir Access Across 120 Countries? - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Upgraded to Buy at Wall Street Zen - MarketBeat
Why Is Gilead Sciences (NASDAQ:GILD) in Focus Across S&P 500? - Kalkine Media
Nykredit A S Invests $140.59 Million in Gilead Sciences, Inc. $GILD - MarketBeat
[Press releases] Gilead Sciences provides updates on access to lenacapavir for HIV prevention - European AIDS Treatment Group
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance
Gilead Sciences (GILD) CFO Andrew Dickinson Sells 3,000 Shares a - GuruFocus
After $435,870 sale, Gilead (NASDAQ: GILD) CFO still holds 164K shares - Stock Titan
Gilead (NASDAQ: GILD) exec sells 3,000 shares in pre-arranged trades - Stock Titan
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):